Turnstone Biologics Corp. (TSBX)
USD 0.45
(-10.36%)
USD 0.45
(-10.36%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 19.3 Million | 73.3 Million | 101.29 Million |
| Cost of Revenue | 2.8 Million | 2.2 Million | 2.01 Million |
| Gross Profit | 16.5 Million | 71.1 Million | 99.28 Million |
| Operating Expenses | 78.33 Million | 104.92 Million | 68.3 Million |
| Selling, General and Administrative Expenses | 17.84 Million | 18.22 Million | 13.54 Million |
| Research and Development Expenses | 60.49 Million | 86.7 Million | 54.75 Million |
| Other Expenses | - | 933 Thousand | 708 Thousand |
| Cost and Expenses | 78.33 Million | 104.92 Million | 68.3 Million |
| Operating Income | -59.03 Million | -31.62 Million | 32.99 Million |
| Interest Expense | - | - | - |
| Income Tax Expense | -286 Thousand | 141 Thousand | 432 Thousand |
| Earnings before Tax | -55.48 Million | -30.69 Million | 33.7 Million |
| Net Income | -55.2 Million | -30.83 Million | 33.26 Million |
| Earnings Per Share Basic | -4.77 | -1.39 | 1.50 |
| Earnings Per Share Diluted | -4.77 | -1.39 | 1.50 |
| Weighted Average Shares Outstanding | 11.56 Million | 22.18 Million | 22.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.56 Million | 22.18 Million | 22.18 Million |
| Gross Margin | 0.85 | 0.97 | 0.98 |
| EBIT Margin | -2.91 | -0.38 | 0.34 |
| Profit Margin | -2.86 | -0.42 | 0.33 |
| EBITDA | -56.23 Million | -28.49 Million | 35.71 Million |
| Earnings Before Tax Margin | -3.06 | -0.43 | 0.33 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 19.3 Million | - | - |
| Cost of Revenue | 500 Thousand | 509 Thousand | 661 Thousand | 2.8 Million | 700 Thousand | 730 Thousand |
| Gross Profit | -500 Thousand | -509 Thousand | -661 Thousand | 16.5 Million | -700 Thousand | -730 Thousand |
| Operating Expenses | 21.55 Million | 20.69 Million | 17.85 Million | 78.33 Million | 18.93 Million | 21.85 Million |
| Selling, General and Administrative Expenses | 4.32 Million | 4.9 Million | 4.39 Million | - | 4.75 Million | 4.65 Million |
| Research and Development Expenses | 17.23 Million | 15.79 Million | 13.45 Million | - | 14.17 Million | 17.19 Million |
| Other Expenses | 755 Thousand | 1.07 Million | 1.24 Million | 3.54 Million | 1.57 Million | 347 Thousand |
| Cost and Expenses | 22.05 Million | 20.69 Million | 17.85 Million | 78.33 Million | 18.93 Million | 21.85 Million |
| Operating Income | -22.05 Million | -20.69 Million | -17.85 Million | -59.03 Million | -18.93 Million | -21.85 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 2000.00 | 16 Thousand | -165 Thousand | -286 Thousand | -33 Thousand | -6000.00 |
| Earnings before Tax | -21.3 Million | -19.61 Million | -16.61 Million | -55.48 Million | -17.35 Million | -21.5 Million |
| Net Income | -21.3 Million | -19.62 Million | -16.45 Million | -55.2 Million | -17.31 Million | -21.49 Million |
| Earnings Per Share Basic | -0.92 | -0.85 | -1.42 | - | -1.00 | -0.97 |
| Earnings Per Share Diluted | -0.92 | -0.85 | -1.42 | - | -1.00 | -0.97 |
| Weighted Average Shares Outstanding | 23.03 Million | 23.01 Million | 11.56 Million | 11.56 Million | 17.39 Million | 22.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 23.03 Million | 23.01 Million | 11.56 Million | 11.56 Million | 17.39 Million | 22.18 Million |
| Gross Margin | - | - | - | 0.85 | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | -2.86 | - | - |
| EBITDA | -21.55 Million | -20.18 Million | -17.19 Million | - | -18.23 Million | -21.12 Million |
| Earnings Before Tax Margin | - | - | - | -3.06 | - | - |
LPA
2986
FNM
STEELCITY
BWLP
600129